| | 66085-59-4 Basic information More.. |
| Product Name: | Nimodipine | | Synonyms: | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid 3-isopropyl 5-(2-methoxyethyl) ester;3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(2-methoxyethyl) 5-(1-methylethyl) ester;Nimodipine,1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester, Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridine;Nimodipime;Isopropyl 2-methoxyethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;Nimodipine (125 mg);NiModipine(NiMotop);1,4-Dihydro-2,6-diMethyl-4-(3-nitrophenyl)- | | CAS: | 66085-59-4 | | MF: | C21H26N2O7 | | MW: | 418.44 | | EINECS: | 266-127-0 | | Mol File: | 66085-59-4.mol |  |
Use
1.Nimodipine should be used for patients with cerebral edema and intracranial hypertension with caution. Nimodipine metabolites has toxicity. So patients with liver dysfunction should be used with caution. Nimodipine can cause a lowering of blood pressure. For patients with hypertensive subarachnoid hemorrhage or stroke patients, the dosage of antihypertensive drugs should be paid attention to be reduced or temporarily stopped, or the dosage of nimodipine should be reduced. That can produce intestinal pseudo-obstruction, manifested as abdominal distension, decreased bowel sounds. When the above symptoms appears, the dosage should be reduced and observation should be hold.
2.Nimodipine can be secreted by milk. Breast-feeding women should not use. Animal experiments suggest that this product has teratogenicity.
- Nimodipine
-
- US $0.00-0.00 / kg
- 2025-05-30
- CAS:66085-59-4
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 20tons
- Nimodipine
-
- US $0.00 / KG
- 2025-05-29
- CAS:66085-59-4
- Min. Order: 1KG
- Purity: 98%min
- Supply Ability: 30tons/month
- Nimodipine
-
- US $33.00 / mg
- 2025-05-22
- CAS:66085-59-4
- Min. Order:
- Purity: 99.79%
- Supply Ability: 10g
|
|
66085-59-4
Recommend Suppliers |
|